Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome.
autoinflammatory disease
biotherapies
interleukin-1
international registry
personalized medicine
rare disease
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
04
2022
accepted:
27
06
2022
entrez:
4
8
2022
pubmed:
5
8
2022
medline:
5
8
2022
Statut:
epublish
Résumé
The present paper describes the design, development, and implementation of the AutoInflammatory Disease Alliance (AIDA) International Registry specifically dedicated to patients with Schnitzler's syndrome. This is a clinical physician-driven, population- and electronic-based registry implemented for the retrospective and prospective collection of real-life data from patients with Schnitzler's syndrome; the registry is based on the Research Electronic Data Capture (REDCap) tool, which is designed to collect standardized information for clinical research, and has been realized to change over time according to future scientific acquisitions and potentially communicate with other existing or future similar registries. Since its launch, 113 centers from 23 countries in 4 continents have been involved. Fifty-seven have already obtained the approval from their local Ethics Committees. The platform counts 324 users (114 Principal Investigators, 205 Site Investigators, 2 Lead Investigators, and 3 data managers) at current (April 28th, 2022). The registry collects baseline and follow-up data using 3,924 fields organized into 25 instruments, including patient's demographics, history, clinical manifestations and symptoms, trigger/risk factors, laboratory, instrumental exams, therapies, socioeconomic information, and healthcare access. This International Registry for patients with Schnitzler's syndrome facilitates standardized data collection, enabling international collaborative projects through data sharing and dissemination of knowledge; in turn, it will shed light into many blind spots characterizing this complex autoinflammatory disorder.
Identifiants
pubmed: 35924038
doi: 10.3389/fmed.2022.931189
pmc: PMC9339622
doi:
Types de publication
Journal Article
Langues
eng
Pagination
931189Informations de copyright
Copyright © 2022 Sota, Vitale, Więsik-Szewczyk, Frassi, Lopalco, Emmi, Govoni, de Paulis, Marino, Gidaro, Monti, Opris-Belinski, Pereira, Jahnz-Rózyk, Gaggiano, Crisafulli, Iannone, Mattioli, Ruffilli, Mormile, Rybak, Caggiano, Airò, Tufan, Gentileschi, Ragab, Almaghlouth, Aboul-Fotouh Khalil, Cattalini, La Torre, Tarsia, Giardini, Ali Saad, Bocchia, Caroni, Giani, Cinotti, Ruscitti, Rubegni, Dagostin, Frediani, Guler, Della Casa, Maggio, Recke, von Bubnoff, Krause, Balistreri, Fabiani, Rigante and Cantarini.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Med Genet A. 2019 Jun;179(6):885-892
pubmed: 30883013
Ophthalmol Ther. 2022 Apr;11(2):899-911
pubmed: 35099782
Value Health. 2018 May;21(5):553-560
pubmed: 29753352
Br J Dermatol. 2006 Oct;155(4):827-9
pubmed: 16965436
Allergy. 2013;68(5):562-8
pubmed: 23480774
Orphanet J Rare Dis. 2018 Aug 28;13(1):147
pubmed: 30153866
Chin Med J (Engl). 2022 May 20;135(10):1190-1202
pubmed: 35089885
Curr Rheumatol Rep. 2017 Aug;19(8):46
pubmed: 28718061
Orphanet J Rare Dis. 2014 Nov 26;9:170
pubmed: 25427578
Ophthalmol Ther. 2022 Apr;11(2):887-897
pubmed: 35092604
Front Med (Lausanne). 2022 Apr 07;9:878797
pubmed: 35463015